What is DrugCard?
DrugCard is an AI‑driven platform that automates literature screening and pharmacovigilance workflows for CROs, MAHs, and independent reviewers.
It applies proprietary OCR to recognize keywords in scanned journal articles with up to 99 % accuracy, enabling rapid identification of drug mentions across 100+ languages and 2,200+ local medical journals.
The system delivers real‑time email alerts and weekly summary reports, providing audit‑ready evidence for adverse event detection, signal management, and regulatory submissions such as DSURs, PSURs, and eCTDlight filings.
DrugCard’s architecture supports scalable, multi‑region deployment, allowing new country journal packs to be added in 2–3 weeks and enabling consistent traceability across global operations.
DrugCard user reviews
Would you recommend DrugCard?
DrugCard's key features
-
AI-driven automated literature screening
-
OCR 99% accuracy
-
Real-time local journal monitoring
-
Instant email notifications for drugs
-
Weekly summary audit reports
-
Scalable to 100+ languages
DrugCard use cases
-
Automate literature screening for clinical trial safety reporting across 2,200 journals, extracting drug mentions in 100+ languages and flagging adverse events in real time for CROs
-
Generate audit‑ready pharmacovigilance reports for regulatory submissions, consolidating OCR‑captured drug data and real‑time alerts to reduce manual reporting time by 60 %
-
Streamline post‑marketing surveillance by continuously scanning global journals, detecting new drug‑adverse event relationships in multiple languages, and delivering instant alerts to pharmacovigilance teams
Who is it for?
-
Regulatory affairs managers
-
Data analysts
-
Pharmacovigilance analysts
-
Clinical researchers
-
Medical practitioners
